Horizon Scanning for Advanced Therapies: From Innovation to Patient Access

29 Jan 2026
Advanced Therapies Stage
  • Insights from NICE on horizon scanning for Cell and Gene Therapies 

  • Identifying, evaluating and preparing for emerging ATMPs in the NHS 

  • Patient-centric approaches, ensuring timely and equitable access to advanced therapies 

Speakers
John Spoors
John Spoors, Programme Director: Commercial, Managed Access and Medicines Policy - NICE